Complete Celiac Testing Timeline: From Symptoms to Results
Understanding the Celiac Testing Timeline When you’re experiencing symptoms or concerned about celiac disease, understanding
Written by Dr. Shelly Gunn
When your genetic test report mentions “DR3-DQ2” or “DR4-DQ8,” you’re looking at haplotypes—specific combinations of genes inherited together. After interpreting thousands of these results, we know that understanding your haplotype configuration is key to assessing your true celiac disease risk.
Haplotypes tell a more complete story than genes alone. They reveal not just which celiac-associated genes you carry, but how they’re arranged on your chromosomes and which other immune genes travel with them. This matters because the risk of celiac disease differs between these haplotypes, with the presence of DR3-DQ2 considered to confer a higher risk than the presence of DR4-DQ8 PubMed Central.
This guide explains what DQ2 and DQ8 haplotypes are, how they differ, and what your specific configuration means for your health.
A haplotype is a set of genes inherited together from one parent. Think of it as a genetic package—multiple genes sitting close together on a chromosome that travel as a unit through generations.
For celiac disease, the important haplotypes include:
DQ2.5cis very frequently appears in linkage disequilibrium with DRB1*03:01 allele PubMed Central, meaning these genes typically inherit together, forming the DR3-DQ2.5 haplotype.
Complete designation: DRB103:01-DQA105:01-DQB1*02:01
The DR3-DQ2.5cis haplotype is present in more than 90% of patients with celiac disease PubMed Central. This is the classic celiac haplotype found in most patients.
Why it confers high risk: The DQ2.5 molecule (formed by DQA105:01 and DQB102:01) excels at binding and presenting gluten peptides. The disease-associated HLA-DQ2.5 molecule presents a large repertoire of gluten peptides PubMed Central, creating multiple opportunities for immune activation.
What “cis” means: Both DQ genes (DQA105:01 and DQB102:01) sit on the same chromosome, inherited from one parent. This cis configuration is genetically linked to DR3 (DRB1*03:01).
Your risk with DR3-DQ2.5:
Complete designation: DRB104-DQA103:01-DQB1*03:02
Almost 90% of celiac patients have HLA-DQ2 or HLA-DQ8 with DR3 haplotype PubMed Central. DQ8 accounts for 5-10% of celiac patients who don’t carry DQ2.5.
Why it confers lower risk than DQ2.5: The DQ8 molecule binds gluten peptides differently than DQ2.5. HLA-DQ8 binds and presents gluten peptides with glutamate at anchor positions P1 and/or P9 PubMed Central, while DQ2.5 uses different anchor positions (P4, P6, P7). This difference affects how efficiently gluten triggers immune responses.
Geographic variation: DR4-DQ8 prevalence varies by region. It’s more common in certain populations and less common in northern Europe where DR3-DQ2.5 dominates.
Your risk with DR4-DQ8: Generally lower than DR3-DQ2.5, but still substantial, especially in two copies or combined with partial DQ2 variants.
Complete designation: DRB107-DQA102:01-DQB1*02:02
DQ2.2 is interesting because it shares the beta chain (DQB102) with DQ2.5 but has a different alpha chain (DQA102:01 instead of DQA1*05:01).
Why DQ2.2 alone rarely causes disease: HLA-DQ2.5 predisposes to celiac disease, HLA-DQ2.2 does not PubMed Central when carried alone. The reason lies in peptide binding: the non-disease-associated HLA-DQ2.2 molecule can present only a subset of gluten peptides PubMed Central that DQ2.5 can present.
The binding motif of DQ2.2 was strikingly different from that of DQ2.5 with position P3 being a major anchor having a preference for threonine and serine PubMed. This specificity limits which gluten peptides DQ2.2 can effectively present.
When DQ2.2 matters: DQ2.2 becomes significant when inherited with DQ2.5 in trans configuration—meaning you have DR7-DQ2.2 from one parent and DR3-DQ2.5 (or DR5 with DQA1*05) from the other. This combination creates functional DQ2.5 molecules through mixing of alpha and beta chains.
Complete designation: DRB111/12-DQA105:01-DQB1*03:01
DR5 carries the alpha chain (DQA105:01) needed for DQ2.5 but pairs it with a different beta chain (DQB103:01).
The trans formation: Some patients carry DQ2.5 risk alleles in trans on the genotype DR7-DQ2.2/DR5-DQ3.5 PubMed Central. When you inherit DR7-DQ2.2 from one parent (providing DQB102:02) and DR5 from the other (providing DQA105:01), your cells can form functional DQ2.5 molecules by combining the alpha chain from one haplotype with the beta chain from the other.
This concept confuses many people, but it’s crucial for understanding risk.
Cis configuration: Both genes needed for a functional HLA molecule are on the same chromosome.
Trans configuration: The two genes needed are on different chromosomes (one from each parent).
Why this matters: HLA-DQ trans dimers formed in HLA-DQ2.5/2.2 heterozygous individuals have properties identical with HLA-DQ2.5 dimers PubMed Central. Trans configurations can create functional risk molecules even when neither individual haplotype seems high-risk alone.
Your actual risk depends not just on individual haplotypes but how they combine.
Configuration: DR3-DQ2.5 / DR3-DQ2.5
This represents the highest genetic risk. In the adjusted model, the hazard ratio for celiac disease autoimmunity was 5.70 among homozygotes, as compared with children who had the lowest-risk genotypes PubMed Central.
Every cell produces only DQ2.5 molecules, maximizing gluten peptide presentation capacity. We routinely see earlier disease onset and sometimes more severe presentations in this group.
Configuration: One DR3-DQ2.5 haplotype, one DR4-DQ8 haplotype
Patients with celiac disease carrying DR3-DQ2/DR4-DQ8 were at higher risk PubMed. This combination is particularly notable for co-occurrence with Type 1 diabetes.
Increased risk for co-occurrence of type 1 diabetes and celiac disease has been reported for DR3-DQ2.5 homozygotes as well as for DR3-DQ2.5/DR4-DQ8 Frontiers. If you have this combination and Type 1 diabetes, your celiac risk is substantially elevated.
Configuration: DR3-DQ2.5 cis plus DR7-DQ2.2
This creates very high risk through multiple mechanisms. You have functional DQ2.5 from the DR3 haplotype, plus cells can form additional DQ2.5 molecules in trans by pairing DQA105 from DR3 with DQB102 from DR7.
The presence of the extra DQB1*02 copy amplifies risk through the gene dose effect.
Configuration: DQB102:02 from DR7 pairing with DQA105:01 from DR5
This is the classic trans configuration. Some patients carry the DQ2.5 risk alleles in trans on the genotype DR7-DQ2.2/DR5-DQ3.5 PubMed Central. While neither haplotype alone confers high risk, together they create functional DQ2.5 molecules.
Your risk with this configuration is intermediate—lower than DR3-DQ2.5 cis but still significant.
Configuration: DR4-DQ8 / non-risk haplotype
Your cells produce some DQ8 molecules that can present gluten, but the risk is relatively low compared to DQ2.5 carriers. Risk conferred by presenting DQ8 in heterozygosity is 1:854 SciELO.
Configuration: DQ2.2 or partial DQ2.5 without complementary haplotype
DQ2.2 carriers (excluding those with also DQ2.5, DQ8 and DQ7.5) have risk of 1:929 SciELO. Without the trans pairing to create full DQ2.5, risk remains very low.
Your haplotype includes more than just DQ genes. HLA-DQ haplotypes are linked to HLA-DR genes, forming HLA-DR-DQ haplotypes Frontiers, and these extended haplotypes carry additional immune genes.
Shared disease associations: HLA DR3 is associated to Graves disease, myasthenia gravis, systemic lupus erythematosus, Hashimoto’s thyroiditis, and type 1 diabetes Frontiers. The DR3 haplotype confers risk for multiple autoimmune conditions, not just celiac disease.
This explains why people with celiac disease often have other autoimmune conditions—they share underlying genetic susceptibility through extended haplotypes.
If you have DR3-DQ2.5:
If you have DR4-DQ8:
If you have DR7-DQ2.2 or DR5-DQ7.5:
If you have DR3-DQ2.5 / DR4-DQ8:
Understanding your haplotype helps determine testing frequency:
Your haplotypes predict what you can pass to children:
Your haplotype explains related conditions:
Your report might show:
Format 1: Full haplotype notation “DR3-DQ2.5 / DR3-DQ2.5” = Homozygous high risk
Format 2: Gene-level notation “DQA105:01-DQB102:01 / DQA105:01-DQB102:01″ = Same as above
Format 3: Simplified DQ typing “DQ2.5 homozygous” = Same information, simplified
All three formats describe the same genetic status. The key is identifying:
Your DQ2 and DQ8 haplotypes represent inherited packages of immune genes that determine celiac disease susceptibility. DR3-DQ2.5 confers the highest risk, present in over 90% of celiac patients. DR4-DQ8 accounts for most remaining cases. Understanding whether your genes are in cis or trans configuration, and how your two haplotypes combine, reveals your true genetic risk.
These haplotypes don’t just predict celiac disease—they’re linked to broader autoimmune susceptibility through extended genetic packages. Armed with this knowledge, you can make informed decisions about testing, monitoring, and understanding your overall autoimmune risk profile.
What’s the difference between DQ2.5 and DQ2.2?
HLA-DQ2.5 predisposes to celiac disease, HLA-DQ2.2 does not PubMed Central when carried alone. DQ2.5 (DQA105:01-DQB102:01) can present a wide range of gluten peptides, while DQ2.2 (DQA102:01-DQB102:02) can present only a limited subset. DQ2.2 becomes significant only when inherited with partial DQ2.5 components in trans configuration, allowing formation of functional DQ2.5 molecules.
My report says “DR3-DQ2.” Is that the same as “DR3-DQ2.5”?
Yes, in most contexts “DR3-DQ2” refers to DR3-DQ2.5, the classic celiac haplotype. Some reports use simplified notation. If your report shows DRB103:01 with DQA105:01 and DQB1*02:01, that’s DR3-DQ2.5. If you’re uncertain, ask your testing provider which specific DQ variant you carry.
Can I develop celiac disease with DR4-DQ8 but no DQ2?
Yes. Almost 95% of patients with celiac disease express HLA-DQ2 and the rest usually carry the HLA-DQ8 heterodimer PubMed Central. DR4-DQ8 alone can cause celiac disease, though it’s less common and generally confers lower risk than DR3-DQ2.5. About 5-10% of celiac patients have DQ8 without DQ2.
What does “trans DQ2.5” mean on my report?
Trans DQ2.5 means you inherited partial DQ2.5 components from each parent that combine to form functional DQ2.5 molecules. Typically, this is DR7-DQ2.2 (providing DQB102) from one parent and DR5 (providing DQA105) from the other. HLA-DQ trans dimers formed in HLA-DQ2.5/2.2 heterozygous individuals have properties identical with HLA-DQ2.5 dimers PubMed Central, meaning trans DQ2.5 confers real celiac risk.
Why does my report mention DR genes if DQ genes cause celiac disease?
DR genes travel with DQ genes as part of extended haplotypes. DQ2.5cis very frequently appears in linkage disequilibrium with DRB1*03:01 allele PubMed Central. Reporting the DR gene helps identify which specific haplotype you carry and indicates which other immune genes you likely have, since DR genes are linked to risks for other autoimmune conditions beyond celiac disease.
Complete Celiac Testing Timeline: From Symptoms to Results
Understanding the Celiac Testing Timeline When you’re experiencing symptoms or concerned about celiac disease, understanding
DQ2 and DQ8 Haplotypes: Your Celiac Genetic Risk Explained
Decoding Your Celiac Disease Haplotypes When your genetic test report mentions “DR3-DQ2” or “DR4-DQ8,” you’re
The Definitive Guide to Celiac Disease Diagnosis 2026
Understanding the Celiac Disease Diagnostic Journey Celiac disease diagnosis isn’t a single test—it’s a systematic